Boston Scientific Neuromodulation Corporation PSC5210W ユーザーズマニュアル
Safety Information
15
Adverse Effects
Potential risks are involved with any surgery. The possible risks of
implanting a pulse generator as part of a system to deliver spinal cord
stimulation include:
Potential risks are involved with any surgery. The possible risks of
implanting a pulse generator as part of a system to deliver spinal cord
stimulation include:
• Lead migration, resulting in undesirable changes in stimulation
and subsequent reduction in pain relief.
• System failure, which can occur at any time due to random fail-
ure(s) of the components or the battery. These events, which may
include device failure, lead breakage, hardware malfunctions,
include device failure, lead breakage, hardware malfunctions,
loose connections, electrical shorts or open circuits and lead insu-
lation breaches, can result in ineffective pain control.
• Tissue reaction to implanted materials can occur.
• Skin erosion at the IPG site can occur over time.
• Possible surgical procedural risks are: temporary pain at the
• Skin erosion at the IPG site can occur over time.
• Possible surgical procedural risks are: temporary pain at the
implant site, infection, cerebrospinal fluid (CSF) leakage and,
although rare, epidural hemorrhage, seroma, hematoma and
paralysis.
• External sources of electromagnetic interference may cause the
device to malfunction and affect stimulation.
• Exposure to MRI can result in heating of tissue, image artifacts,
induced voltages in the neurostimulator and/or leads, lead dis-
lodgement.
lodgement.
• Undesirable stimulation may occur over time due to cellular
changes in tissue around the electrodes, changes in electrode
position, loose electrical connections and/or lead failure.
• The patient may experience painful electrical stimulation of the
chest wall as a result of stimulation of certain nerve roots several
weeks after surgery.
weeks after surgery.
• Over time, the Stimulator may move from its original position.
• Weakness, clumsiness, numbness or pain below the level of
• Weakness, clumsiness, numbness or pain below the level of
implantation.
• Persistent pain at the IPG or lead site.
In any event, instruct the patient to contact their physician to inform
him/her.
him/her.